Endometrial Atypical Hyperplasia: Clinical Trials

2 trials for Endometrial Atypical Hyperplasia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Not yet recruiting 1

Follow Endometrial Atypical Hyperplasia: new trials by email Literature Review of Endometrial Atypical Hyperplasia trials Research Report on Endometrial Atypical Hyperplasia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Semaglutide, Weight Loss, and LNG-IUD for Conservative Treatment of Endometrial Atypical Hyperplasia and Grade 1 Endometrial Cancer
Semaglutide (Wegovy) weekly injection, LNG-IUD (Progestin), Structured Weight Loss Program - Endometrial Atypical Hyperplasia, Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia
Phase 2Not yet recruitingThe Methodist Hospital Research Institute482027-01-012026-10-01
Megestrol Acetate Plus Metformin to Megestrol Acetate in Patients With Endometrial Atypical Hyperplasia or Early Stage Endometrial Adenocarcinoma
Megestrol acetate and metformin, Megestrol acetate - Endometrial Atypical Hyperplasia, Endometrial Adenocarcinoma
Phase 2CompletedXiaojun Chen1502013-10-012021-09-14

Narrower conditions

Endometrial Hyperplasia (2)  ·  Endometrial Neoplasms (1)  ·  Obesity (1)  ·  Overweight (1)  ·  Weight Loss (1)

Broader conditions

Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Genital Diseases (2)  ·  Genital Diseases, Female (2)  ·  Urogenital Diseases (2)  ·  Uterine Diseases (2)  ·  Body Weight (1)  ·  Body Weight Changes (1)  ·  Genital Neoplasms, Female (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Nutrition Disorders (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Overnutrition (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Megestrol Acetate (1)  ·  Metformin (1)  ·  semaglutide (1)

Sponsors

The Methodist Hospital Research Institute (1)  ·  Xiaojun Chen (1)

Countries

China (1)  ·  United States (1)

Top investigators

Aparna A. Kamat, MD (1)  ·  Xiaojun Chen, PhD (1)